Antibiotics | Susceptibility rate % | ESBL (n = 29) | Non-ESBL (n = 55) | p-value* | |
---|---|---|---|---|---|
R | S | ||||
AM | 97.6 | 2.4 | 29 (100%) | 50 (91 %) | 0.4 |
AMC | 85.7 | 14.3 | 24 (82.7%) | 15 (27.3%) | 10−4 |
AMX | 95.2 | 4.8 | 29 (100%) | 49 (89.1%) | 0.17 |
IPM | 3.6 | 96.4 | 01 (3.4%) | 00 (0%) | 0.3 |
CTX | 56.5 | 40.5 | 28 (96.5%) | 01 (1.8%) | <10−9 |
CRO | 44.7 | 58.3 | 28 (96.5%) | 01 (1.8%) | 10−3 |
CIP | 91.7 | 8.3 | 29 (100%) | 14 (25.5%) | 10−10 |
NOR | 53.6 | 46.4 | 28 (96.5%) | 14 (25.5%) | <10−9 |
AN | 83.3 | 16.7 | 21(72.4%) | 19 (34.5%) | 0.04 |
G | 45.2 | 54.8 | 24 (82.7) | 12 (21.8) | 10−7 |
SXT | 86.9 | 13.1 | 29 (100%) | 43 (78.2%) | 6.10−3 |